Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引：0
|
作者：
Bedoya Serna, Beatriz Eugenia [1 ]
机构：
[1] Corp Invest Biol, Medellin, Colombia
来源：
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词：
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I：
10.30554/archmed.19.1.2791.2019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数：12
相关论文
共 50 条
  • [1] Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: a cross-sectional study
    Huang, Huaping
    Yuan, Guosheng
    Du, Yuhua
    Cai, Xiaoting
    Liu, Junwei
    Hu, Chengguang
    Liang, Bing
    Hu, Guifang
    Tang, Xiaoping
    Zhou, Yuanping
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 4377 - 4386
  • [2] Factors Associated with Absence of Active Pulmonary Tuberculosis in HIV Patients with Latent Tuberculosis, Beyond Isoniazid Preventive Therapy
    Yuniati, Shinta Karina
    Kusmiati, Tutik
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2024, 13 (03) : 293 - 298
  • [3] Preventive therapy for tuberculosis in HIV infection
    Brewer, TF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (10): : 881 - 882
  • [4] Tests for latent tuberculosis infection and isoniazid preventive therapy
    Dowdy, David W.
    Golub, Jonathan E.
    LANCET INFECTIOUS DISEASES, 2012, 12 (11): : 827 - 828
  • [5] Relation Risk Factors with Latent Tuberculosis Infection (LTBI) in HIV Patients
    Reviono
    Harsini
    Irwandi, D.
    ADVANCED SCIENCE LETTERS, 2018, 24 (09) : 6852 - 6855
  • [6] Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations
    Cohen, T
    Lipsitch, M
    Walensky, RP
    Murray, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) : 7042 - 7047
  • [7] Preventive therapy for latent tuberculosis infection-the promise and the challenges
    Fox, G. J.
    Dobler, C. C.
    Marais, B. J.
    Denholm, J. T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 56 : 68 - 76
  • [8] Adherence to latent tuberculosis infection therapy among latino immigrants
    Ailinger, Rita L.
    Moore, Jean B.
    Nguyen, Nga
    Lasus, Howard
    PUBLIC HEALTH NURSING, 2006, 23 (04) : 307 - 313
  • [9] Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
    Shayo, Grace A.
    Moshiro, Candida
    Aboud, Said
    Bakari, Muhammad
    Mugusi, Ferdinand M.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [10] Predictors of adherence to latent tuberculosis infection therapy in Latino immigrants
    Ailinger, Rita L.
    Black, Pat
    Nguyen, Nga
    Lasus, Howard
    JOURNAL OF COMMUNITY HEALTH NURSING, 2007, 24 (03) : 191 - 198
12345